A person living in Glasgow is more than four times as likely to die prematurely from cardiovascular disease (CVD) than someone living in Hart in Hampshire, according to new statistics from the British Heart Foundation (BHF).

The charity released the figures as it launched its new strategyto fight heart and circulatory disease through pioneering research and tackling the unacceptable divide in the nation’s heart health.

Simon Gillespie, Chief Executive of the BHF said: "These figures are a stark reminder of the unacceptable number of people that lose their lives to cardiovascular disease every year, often increased by the place they live. There is still so much more we need to do.

"We’ve made huge progress in the fight against cardiovascular disease, with 70% of heart attack victims now surviving to go home to their families. With the help of our supporters, we’ll increase investment and accelerate our world-class research that could save the lives of more people that die prematurely. We remain determined to win the fight against cardiovascular disease, improving the lives of the seven million people living with it and saving those that currently die too young."

Further reading: GM Conference report - Managing anticoagulation in the elderly patient
To book your place at this year's GM Conference visit:
www.gmjournal.co.uk/managing-an-ageing-patient-from-midlife-to-beyond/  

The figures, published in BHF's Strategy to 2020, reveal significant inequalities in deaths from heart and circulatory disease across different parts of the UK. Areas including Inverclyde and Dundee in Scotland, and Manchester and Blackpool in the North West are also hotspots for high rates of early deaths.

Other key facts included:
• 35% more people suffer a heart attack or stroke than was previously estimated, with the annual figure reaching 410,000.
• In total, more than 100 people under the age of 75 die from CVD each day, the equivalent of 42,000 people a year.
• Over 7 million people are living with CVD across the UK.
• CVD accounts for more than one in four of all UK deaths.

To view our infographic on the BHF's latest CV statistics visit:
http://www.pinterest.com/pin/455145106065191403/  

Dr Shanthi Mendis, Senior Adviser of the World Health Organisation said: "The work of the BHF and its partners to address cardiovascular disease will be vital to the UK contributing to the global target of cutting premature deaths from non-communicable diseases by 25% by 2025.”

"Research breakthroughs have played a major role in the halving of premature deaths in the under 75s over the last 20 years. Advances in heart attack treatments mean 70 per cent of victims leave hospital alive and the use of statins is helping millions cut their risk of having a heart attack."

The BHF’s strategy offers a new focus on reducing the time it takes to turn research discoveries into life-saving medical treatments. For the first time the BHF will fund dedicated translational research awards totalling £5 million over five years, which will explicitly bridge the gap between a scientist’s initial findings and the treatments that will change and extend the lives of heart patients.

To find out more about the strategy go to www.bhf.org.uk/strategy